STAT Signaling
- F2114 Anti-EGFR Antibody (Nimotuzumab)Summary: Anti-EGFR Antibody (Nimotuzumab)
- F1401 Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab emtansine)Summary: Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab emtansine)
- F1402 Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab deruxtecan)Summary: Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab deruxtecan)
- F1403 Anti-ERBB2/HER2/CD340 Antibody (Disitamab vedotin)Summary: Anti-ERBB2/HER2/CD340 Antibody (Disitamab vedotin)
- F1404 Anti-ERBB1/EGFR/HER1 Antibody (Cetuximab)Summary: Anti-ERBB1/EGFR/HER1 Antibody (Cetuximab)
- F1405 Anti-ERBB1/EGFR/HER1 Antibody (Necitumumab)Summary: Anti-ERBB1/EGFR/HER1 Antibody (Necitumumab)
- F1406 Anti-ERBB1/EGFR/HER1 Antibody (SerclutamAb)Summary: Anti-ERBB1/EGFR/HER1 Antibody (SerclutamAb)
- F1407 Anti-ERBB2/HER2/CD340 Antibody (Pertuzumab)Summary: Anti-ERBB2/HER2/CD340 Antibody (Pertuzumab)
- F1408 Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab)Summary: Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab)
- F1409 Anti-ERBB2/HER2/CD340 Antibody (Disitamab)Summary: Anti-ERBB2/HER2/CD340 Antibody (Disitamab)